warning about reports of acute renal failure with Immune Globulin Intravenous (IVIG) products
January 1999
The FDA is now warning about reports of acute renal failure with Immune Globulin Intravenous (IVIG) products.
The risk appears to be highest with products that contain sucrose...Sandoglobulin, Panglobulin, and Gammar-P IV. These solutions can cause kidney damage due to their higher osmotic load.
Patients at increased risk are primarily those with pre-existing renal dysfunction...diabetes...and over 65.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote